Skip to main content
Clinical Trials/CTRI/2023/05/052157
CTRI/2023/05/052157
Not yet recruiting
未知

Pattern of treatment and outcomes in patients with recurrent and/or metastatic triple negative breast cancer - A single institute retrospective analysis - Metastatic TNBC

Tata Memorial Centre0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Sponsor
Tata Memorial Centre
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • All individuals above 18 years of age having histopathologically proven, recurrent and/or metastatic triple negative breast cancer (mTNBC) during the period of January 2015 to June 2022\.
  • Patients could have received any number of lines of treatment in the metastatic and/or recurrent setting.

Exclusion Criteria

  • Patients with breast cancer without triple negative disease.

Outcomes

Primary Outcomes

Not specified

Similar Trials